MJDNET LIMITED

Financial Health Assessment: MJDNET LIMITED

1. Financial Health Score: D+

The patient is technically alive and showing signs of activity after a prolonged period of dormancy, but it is suffering from severe financial anemia. The business possesses minimal financial reserves to survive any unexpected shocks or market illnesses.

2. Key Vital Signs

• Pulse (Turnover): £8,974 – A weak but present heartbeat. After four years of flatlining (£0 turnover from 2020-2024), the company generated modest revenue in 2025. However, for an IT consultancy, this is an extremely low volume of activity—barely enough to sustain life.
• Blood Pressure (Net Assets): £454 – Dangerously low. The company’s net assets are thin, meaning there is almost no cushion to absorb losses. While an improvement from the £1 net assets held during the 2018-2023 dormant period, this represents a very fragile financial state.
• Cholesterol (Total Liabilities vs. Total Assets): £2,648 / £4,282 – Elevated. The company has accumulated debts that are disproportionate to its size. The liabilities are over 5 times the size of the business's net worth, restricting healthy cash flow.
• Oxygenation (Profitability): £0 – The business is not retaining any oxygen. Despite generating £8,974 in revenue, the profit for the period is exactly £0. All incoming oxygen is being immediately consumed by expenses (£4,110 in materials and £4,864 in "other charges").

3. Diagnosis: Chronic Micro-Entity Anemia with Symptoms of Extracted Surplus

Looking at the patient's medical history, MJDNET LIMITED spent roughly half a decade in a financial coma. From 2018 to 2024, the company displayed almost zero activity, holding just £1 in net assets. Prior to that, in 2016, the company was technically insolvent (net assets of £-1,183) before a mysterious recovery in 2017.

In the latest period (ending April 2025), the patient has awoken. However, the diagnosis reveals a classic pattern for micro-entities: Lifestyle Business Syndrome. The exact zero-profit figure (£8,974 revenue minus £8,974 total costs) strongly suggests that the sole director is extracting all surplus value as remuneration (categorized under "other charges"), leaving the corporate body with no retained nutrients.

While there is nothing inherently wrong with a director extracting their fair wages, this practice leaves the corporate entity itself with no immune system. With only £454 in net assets, a single unpaid invoice or minor dispute could send the company back into insolvency.

4. Recommendations: Prescriptions for Financial Wellness

To improve the financial resilience of this business and build a healthier balance sheet, the following treatments are recommended:

• Vitamin Injections (Build Retained Earnings): Rather than extracting every penny of profit, aim to retain a small percentage of earnings within the company each year. Building net assets to at least a few thousand pounds will provide a vital buffer against unexpected costs.
• Debt Management Plan (Review Liabilities): With £2,648 in liabilities against minimal assets, the company is over-leveraged. Investigate the nature of these creditors—particularly the amounts falling due after more than one year. Creating a structured plan to pay down this debt will lower financial blood pressure.
• Nutritional Diet (Diversify Revenue Streams): A turnover of £8,974 is not sufficient for long-term survival. The business needs to acquire new clients or projects to increase its top-line revenue, ensuring that fixed costs and director remuneration are comfortably covered by a wider client base rather than a few sporadic engagements.
• Regular Check-ups (Accurate Forecasting): Given the history of dormancy followed by sudden activity, implement quarterly financial reviews to ensure the business maintains a steady pulse and does not slip back into a dormant state.